Cost-effectiveness of early intervention in psychosis in low- and middle-income countries: economic evaluation from São Paulo, Brazil.

AIMS: The effectiveness and cost-effectiveness of early intervention for psychosis (EIP) services are well established in high-income countries but not in low- and middle-income countries (LMICs). Despite the scarcity of local evidence, several EIP services have been implemented in LMICs. Local evaluations are warranted before adopting speciality models of care in LMICs. We aimed to estimate the cost-effectiveness of implementing EIP services in Brazil. METHODS: A model-based economic evaluation of EIP services was conducted from the Brazilian healthcare system perspective. A Markov model was developed using a cohort study conducted in São Paulo. Cost data were retrieved from local sources. The outcome of interest was the incremental cost-effectiveness ratio (ICER) measured as the incremental costs over the incremental quality-adjusted life-years (QALYs). Sensitivity analyses were performed to test the robustness of the results. RESULTS: The study included 357 participants (38% female), with a mean (SD) age of 26 (7.38) years. According to the model, implementing EIP services in Brazil would result in a mean incremental cost of 4,478 Brazilian reals (R$) and a mean incremental benefit of 0.29 QALYs. The resulting ICER of R$ 15,495 (US dollar [USD] 7,640 adjusted for purchase power parity [PPP]) per QALY can be considered cost-effective at a willingness-to-pay threshold of 1 Gross domestic product (GDP) per capita (R$ 18,254; USD 9,000 PPP adjusted). The model results were robust to sensitivity analyses. CONCLUSIONS: This study supports the economic advantages of implementing EIP services in Brazil. Although cultural adaptations are required, these data suggest EIP services might be cost-effective even in less-resourced countries.

The Expression of NF-kB Signaling Pathway Was Inhibited by Silencing TGF-b4 in Chicken IECs Infected with E. tenella

Chicken coccidiosis is a parasitic disease caused by one or more species of Eimeria infection with severe consequences. The NF-B signaling pathway and TGF-4 play an important role in the inflammation and immune response caused by coccidiosis infection. This study was designed to investigate the changes of NF-B signaling pathway and the effects of TGF-4 silencing on the expression of NF-B signaling pathway in chickens intestinal epithelial cells (IECs) after infecting with E. tenella sporozoites. TGF-4 small interfering RNA (TGF-4 siRNA) sequences were transfected into chicken IECs for reducing TGF-4 expression. The results showed that compared with uninfected control group (Con.), the proinflammatory factors of NF-B, IL-6, IL-2, IL-1 increased significantly in the E. tenella infected group (ET) (p 0.05). In comparison with the IECs in the ET, the expression level of NF-B, IL-6, IL-2, IL-1 dropped significantly in the group infected both by E. tenella and TGF-4 siRNA vector (ET+siRNA) (p 0.05). The results of this experiment indicate that NF-B signaling pathway is closely correlated with TGF-4 in IECs infected with coccidia sporozoites. TGF-4 plays an important role in regulating the immune function of coccidia-infected chicken epithelial cells through NF-B signaling pathway and preventing immune-mediated pathological changes.

The Expression of NF-kB Signaling Pathway Was Inhibited by Silencing TGF-b4 in Chicken IECs Infected with E. tenella

Chicken coccidiosis is a parasitic disease caused by one or more species of Eimeria infection with severe consequences. The NF-B signaling pathway and TGF-4 play an important role in the inflammation and immune response caused by coccidiosis infection. This study was designed to investigate the changes of NF-B signaling pathway and the effects of TGF-4 silencing on the expression of NF-B signaling pathway in chickens intestinal epithelial cells (IECs) after infecting with E. tenella sporozoites. TGF-4 small interfering RNA (TGF-4 siRNA) sequences were transfected into chicken IECs for reducing TGF-4 expression. The results showed that compared with uninfected control group (Con.), the proinflammatory factors of NF-B, IL-6, IL-2, IL-1 increased significantly in the E. tenella infected group (ET) (p 0.05). In comparison with the IECs in the ET, the expression level of NF-B, IL-6, IL-2, IL-1 dropped significantly in the group infected both by E. tenella and TGF-4 siRNA vector (ET+siRNA) (p 0.05). The results of this experiment indicate that NF-B signaling pathway is closely correlated with TGF-4 in IECs infected with coccidia sporozoites. TGF-4 plays an important role in regulating the immune function of coccidia-infected chicken epithelial cells through NF-B signaling pathway and preventing immune-mediated pathological changes.(AU)

Hypoxia-induced LncRNA PCGEM1 promotes invasion and metastasis of gastric cancer through regulating SNAI1.

PURPOSE: Hypoxia is an indispensable factor in the progression of metastasis. Hypoxia inducible factor-1α (HIF-1α), the core element in generating the hypoxia response, induces invasion and metastasis by promoting epithelial-mesenchymal transition (EMT). This study explored the underlying mechanism of hypoxia associated with the invasion and metastasis of gastric cancer (GC). METHODS: Six methods were employed to assess the function of the long noncoding RNA (lncRNA) prostate cancer gene expression marker 1 (PCGEM1) including gene silencing, RT-PCR, the separation of nuclear and cytoplasmic fractions, scrape motility assay, transwell migration assay, and Western-blot. RESULTS: LncRNA PCGEM1 was overexpressed in GC cells and tissues, and was induced by hypoxia in GC cells. Additional experiments confirmed that the knockdown of PCGEM1 significantly repressed the invasion and metastasis of GC cells. SNAI1, a key transcription factor of EMT, was regulated by PCGEM1. Overexpression of SNAI1 rescued the inhibition of PCGEM1-knockdown during the invasion and metastasis of GC cells. In addition, PCGEM1 and SNAI1 jointly affected the biomarkers of EMT. CONCLUSION: Our findings indicated that PCGEM1 is a hypoxia-responsive lncRNA, and contributes to the invasion and metastasis of GC. The potential mechanism is attributed to the regulation of EMT by PCGEM1 and its influence on the expression of SNAI1.

Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with 125I seeds intracavitary irradiation.

PURPOSE: This study aimed at investigating the efficacy of percutaneous transhepatic biliary stenting (PTBS) combined with 125I seeds intracavitary irradiation in the treatment of extrahepatic cholangiocarcinoma (EHC) and to preliminarily explore the prognostic values of inflammation-based scores in these patients. METHODS: A total of 113 clinically/pathologically diagnosed cases of EHC who received PTBS combined with 125I seeds implantation were retrospectively analyzed. The postoperative changes of clinical symptoms and serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total serum bilirubin (TBIL), direct bilirubin (DBIL), and albumin (ALB) were observed. Preoperative clinical data were extracted to calculate inflammation-based scores, including systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and platelets-to-lymphocyte ratio (PLR). Kaplan-Meier survival curves and Cox regression analyses were used to evaluate the prognostic significance of inflammation-based scores. RESULTS: After operation, clinical symptoms such as jaundice and fever significantly improved in all patients. At 1 month and 3 months postoperatively, serum levels of ALT, AST, ALP, TBIL, and DBIL significantly reduced, and ALB significantly increased, compared with preoperative values. The median survival time of the patients was 12 months and the 1-year survival rate was 56.8%. Univariate analysis revealed that factors related to overall survival were CA19-9, TBIL, ALB, SII, and NLR. Multivariate analysis further identified SII and NLR as independent prognostic models. CONCLUSION: The combination of PTBS and 125I seeds intracavitary irradiation is an effective palliative treatment for advanced EHC. Elevated SII and NLR can be used to predict poor survival.

Ginsenoside Rg1 protects human renal tubular epithelial cells from lipopolysaccharide-induced apoptosis and inflammation damage

Ginsenoside Rg1, one of the most notable active components of Panax ginseng, has been widely reported to exert anti-inflammatory actions. This study aimed to reveal whether ginsenoside Rg1 also exhibits beneficial roles against lipopolysaccharide (LPS)-induced apoptosis and inflammation in human renal tubular epithelial cells, and to evaluate the potential role of the component on tubulointerstitial nephritis treatment. HK-2 cells were treated with various doses of ginsenoside Rg1 (0, 50, 100, 150, and 200 μM) in the absence or presence of 5 μg/mL LPS. Thereafter, CCK-8 assay, flow cytometry, western blot, migration assay, reactive oxygen species (ROS) assay, and ELISA were carried out to respectively assess cell viability, apoptosis, migration, ROS activity, and the release of inflammatory cytokines. As a result, ginsenoside Rg1 protected HK-2 cells from LPS-induced injury, as cell viability was increased, cell apoptosis was decreased, and the release of MCP-1, IL-1β, IL-6, and TNF-α was reduced. Ginsenoside Rg1 functioned to HK-2 cells in a dose-dependent manner, and the 150 μM dose exhibited the most protective functions. Ginsenoside Rg1 had no significant impact on cell migration and ROS activity, while it alleviated LPS-induced ROS release and migration impairment. Furthermore, the down-regulations of p-PI3K, p-AKT, and up-regulations of PTEN, p-IκBα, p-p65, Bcl-3 induced by LPS were recovered to some extent after ginsenoside Rg1 treatment. In conclusion, ginsenoside Rg1 protects HK-2 cells against LPS-induced inflammation and apoptosis via activation of the PI3K/AKT pathway and suppression of NF-κB pathway.

Ginsenoside Rg1 protects human renal tubular epithelial cells from lipopolysaccharide-induced apoptosis and inflammation damage.

Ginsenoside Rg1, one of the most notable active components of Panax ginseng, has been widely reported to exert anti-inflammatory actions. This study aimed to reveal whether ginsenoside Rg1 also exhibits beneficial roles against lipopolysaccharide (LPS)-induced apoptosis and inflammation in human renal tubular epithelial cells, and to evaluate the potential role of the component on tubulointerstitial nephritis treatment. HK-2 cells were treated with various doses of ginsenoside Rg1 (0, 50, 100, 150, and 200 µM) in the absence or presence of 5 µg/mL LPS. Thereafter, CCK-8 assay, flow cytometry, western blot, migration assay, reactive oxygen species (ROS) assay, and ELISA were carried out to respectively assess cell viability, apoptosis, migration, ROS activity, and the release of inflammatory cytokines. As a result, ginsenoside Rg1 protected HK-2 cells from LPS-induced injury, as cell viability was increased, cell apoptosis was decreased, and the release of MCP-1, IL-1ß, IL-6, and TNF-α was reduced. Ginsenoside Rg1 functioned to HK-2 cells in a dose-dependent manner, and the 150 µM dose exhibited the most protective functions. Ginsenoside Rg1 had no significant impact on cell migration and ROS activity, while it alleviated LPS-induced ROS release and migration impairment. Furthermore, the down-regulations of p-PI3K, p-AKT, and up-regulations of PTEN, p-IκBα, p-p65, Bcl-3 induced by LPS were recovered to some extent after ginsenoside Rg1 treatment. In conclusion, ginsenoside Rg1 protects HK-2 cells against LPS-induced inflammation and apoptosis via activation of the PI3K/AKT pathway and suppression of NF-κB pathway.

The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.

Pancreatic cancer is one of the most deadly cancers, with dismal prognosis due to its poor early detection rate and high metastatic rate. Thus, elucidation of the molecular mechanisms accounting for its metastasis and discovery of competent biomarkers is required. Exosomes are multivesicular body-derived small extracellular vesicles released by various cell types that serve as important message carriers during intercellular communication. They are also known to play critical roles during cancer-genesis, cancer-related immune reactions, and metastasis. They also possess promising potential as novel biomarkers for cancer early detection. Therefore, extensive studies on pancreatic cancer-derived exosomes are currently being performed because they hold the promising potential of elevating the overall survival rate of patients with pancreatic cancer. In the present review, we focus on the role of exosomes in pancreatic cancer-related immune reactions, metastasis, and complications, and on their potential application as pancreatic cancer biomarkers.

Retraction RETRACTION of "Methylation of the RASSFIA promoter in breast cancer" by Y. Ji, H.H. Jin, M.D. Wang, W.X. Cao, J.L. Bao - Genet. Mol. Res. 15 (2): gmr.15028261 (2016) - DOI: 10.4238/gmr.15028261.

The retracted article is: Ji Y, Jin HH, Wang MD, Cao WX, et al. (2016). Methylation of the RASSFIA promoter in breast cancer. Genet. Mol. Res. 15: gmr.15028261. There are significant parts of this article (particularly, in the discussion section) that are copied from "Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome", by Jia Xu, Priya B Shetty, Weiwei Feng, Carol Chenault, Robert C Bast Jr, Jean-Pierre J Issa, Susan G Hilsenbeck and Yinhua Yu, published in BMC Cancer 2012; 12: 243. DOI: 10.1186/1471-2407-12-243. The first paragraphs of both discussions are identical. This is concerning. The abstract and introduction sections have much of their text plagiarized. Overall, there is high plagiarism detected. The GMR editorial staff was alerted and after a thorough investigation, we have strong reason to believe that the peer review process was failure and, after review and contacting the authors, the editors of Genetics and Molecular Research decided to retract the article in accordance with the recommendations of the Committee on Publication Ethics (COPE). The authors and their institutions were advised of this serious breach of ethics.

Methylation of the RASSFIA promoter in breast cancer.

Tumor suppressor genes are the key targets of hypermethylation in breast cancer and may therefore lead to malignancy by deregulation of cell growth and division. Our previous pilot study with pairs of malignant and normal breast tissues identified a correlation between RASSFIA gene methylation and breast cancer. To determine the relationship between RASSFIA methylation and breast cancer, we conducted a larger study. We took samples from 108 patients with breast cancer, 28 patients with benign breast tumors, and 33 subjects with normal breast tissues at the Second Affiliated Hospital of Nanjing Medical University at Wuxi between July 2013 and September 2015. We used the samples to investigate methylation levels of the RASSF1A gene for associations with breast cancer. Quantitative real-time polymerase chain reaction (PCR) and methylation-specific PCR were used to investigate the levels of RASSF1A mRNA expression and RASSF1A methylation, respectively. RASSFIA was not expressed in 22 of the 108 breast cancer tissue samples (20.37%), and there was no statistically significant difference (P > 0.05); however, RASSFIA expression was significantly lower than that in the normal breast tissue samples (P < 0.05). Moreover, the methylation rate of the RASSFIA gene promoter was significantly higher in the breast cancer tissues (64.81%) than in the normal breast tissues (18.18%) and benign breast tumors (17.86%) (P < 0.05). High methylation of the RASSF1A gene promoter was an important reason for its downregulation, and the gene played a critical regulated role in the incidence and development of breast cancer.

Association of Beclin-1 and microRNA-30a expression with the severity and treatment response of colorectal cancer.

We investigated the associations between Beclin-1 and microRNA-30a (miR-30a) expression and the severity and treatment response in colorectal cancer (CRC). Our sample size consisted of 139 CRC patients who were treated with surgery alone. Immunohistochemistry was used to investigate the expression and prognostic significance of Beclin-1 in CRC, while the weak expression of Beclin-1 in normal tissue was used as the basis for assessing tumors (control group). Real-time reverse transcription-polymerase chain reaction quantified miR-30a levels. The expression levels of Beclin-1 and miR-30a were associated with clinical variables and prognoses. Beclin-1 was expressed more highly in CRC tissues than in controls. This expression was related to gender (P = 0.023), histological grade (P = 0.006), M stage (P = 0.004), tumor node metastasis stage (P = 0.020), vascular invasion, and nodal involvement. Patients with higher Beclin-1 expression levels had higher survival rates (P = 0.08) than patients with lower Beclin-1 expression levels. Beclin-1 was a prognostic indicator (P < 0.05) in a multivariate analysis. Beclin-1 was overexpressed in CRC tissues and was correlated with lower levels of miR-30a (P < 0.05, r = -0. 4189). In conclusion, Beclin-1 was a good prognostic indicator in CRC and was correlated with survival rate. Beclin-1 is important in the growth and metastasis of CRC. Apoptosis in CRC might be due to the increased autophagy induced by decreased levels of miR-30a.

Development and characterization of Rift Valley fever virus-like particles.

Rift Valley fever (RVF) is an acute, febrile zoonotic disease that is caused by the RVF virus (RVFV) and spread by arthropod vectors. RVF is currently prevalent in Africa and the Arabian Peninsula, and causes substantial economic losses. Furthermore, this disease poses a serious threat to animal and human health in regions worldwide, making it a serious public health concern. However, RVFV vaccines for human use are still unavailable, and hence there is an urgent need for novel efficient vaccines against RVFV. Vaccine preparation techniques have become a crucial factor in developing new vaccines. In the current study, the N and G protein genes of RVFV were inserted into the pFastBacDual baculovirus expression vector downstream of the pP10 and pPH promoters. The resultant recombinant vector, pFastBacDual-S-M, was transfected into Sf9 insect cells by lipofection. The recombinant baculovirus, named rBac-N-G, was retrieved and infected into Sf9 insect cells to generate RVFV virus-like particles (VLPs). Using polyclonal antibodies against RVFV proteins in immunofluorescence and western blot analyses, we positively identified the presence of the RVFV proteins in VLP preparations. Sucrose density gradient centrifugation and transmission electron microscopy revealed that the morphology of the RVFV VLPs was consistent with previous reports of RVFV virions. This study describes a technique for efficient production of RVFV VLPs, and has laid the foundation for future VLP-based RVFV vaccines.

Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells.

The aim of the present study was to determine the anti-proliferative and pro-apoptotic effects of dihydromyricetin (DHM) on the AGS human gastric cancer cells and their underlying mechanisms. The effects of DHM on AGS cells were evaluated by using 3-(4, 5-di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), lactate dehydrogenase, and Annexin V/propidium iodide (PI) double-staining assays. The underlying mechanisms were determined by using quantitative real-time polymerase chain reaction. The results demonstrated that DHM significantly (P < 0.05) inhibited AGS cell proliferation and induced cell cytotoxicity in a dose- and time-dependent manner. Additionally, Annexin V/PI double-staining assay showed that DHM promoted cell apoptosis in both, early and late stages. Furthermore, DHM also regulated the expression of apoptotic genes such as p53 and B-cell lymphoma-2 (bcl-2) in a dose- and time-dependent manner. In conclusion, this is the first report demonstrating the anticancer and pro-apoptosis effects of DHM on AGS human gastric cancer cells. The results strongly suggest that DHM may be a potential therapeutic candidate for the treatment of gastric cancer.

Changes in cFLIP expression in the corpus luteum throughout the estrous cycle of Shibagoats.

Changes in the expression of the anti-apoptotic protein cFLIP (cellular FLICE inhibitory protein) were examined in the caprine corpus luteum (CL), during development and subsequent maintenance. Corpora lutea at four different stages were collected from Shiba goats, to measure the expression of cFLIP mRNA, protein and immunolocalization. Expression of short form cFLIP (cFLIPS) mRNA was highest at the early CL stage, and decreased during late and regressed stages (P < 0.05). In contrast, long form cFLIP (cFLIPL) mRNA expression was high during early, mid and late stages, and only decreased at the regressed stage (P< 0.01). Protein expression of cFLIPS was highest at the late CL stage, and decreased at the regressed stage (P < 0.01). Protein expression of cFLIPL was highest at the early and mid CL stages, and decreased by the late and regressed stages (P < 0.01). Further expression of cFLIPL was higher at the early CL stage than at the mid stage (P < 0.01). cFLIP protein expression was detectable by immunostaining in the early, mid and late CL stages, but not at the regressed CL stage. These results are consistent with the hypothesis that cFLIP acts as a survival factor in the maintenance of CL function in goats.

Expression and localization of cFLIP anti-apoptotic protein in the porcine corpus luteum and corpora albicans during the estrous cycle and pregnancy.

We determined expression and localization of the anti-apoptotic cellular FLICE inhibitory protein (cFLIP) in the porcine corpora lutea (CL) and corpus albicans (CA) during estrous and pregnancy. The CL and CA were collected at different stages of estrous to determine cFLIP immunolocalization, and mRNA and protein expression. The mRNA expression of the short cFLIP isoform (cFLIPS) was higher at the early and mid CL stages, and lower by the late CL stage (P < 0.01); mRNA expression of the long cFLIP isoform (cFLIPL) was higher at the mid CL stage, and lower at the early and late CL stages (P < 0.01). Levels of cFLIPS and cFLIPL were steady and high during the early and mid CL stages, and had significantly decreased (P < 0.01) by the late stage. The cFLIP protein was highly expressed in the early and mid CL stages of estrous, but weakly ex-pressed in the late stage. Expression of cFLIPS showed no significant difference between preovulatory corpus albicans (CA1) and corpus albicans (CA2) coexistent with the CL from the previous estrus, but cFLIPL mRNA expression was higher during CA1 than CA2. The expression of cFLIPS showed no significant difference between CA1 and CA2, but cFLIPL was not detected. The cFLIP protein was weak-ly expressed in the CA. Expression of cFLIPS and cFLIPL mRNA and proteins was observed in the CL, and the cFLIP protein was highly expressed during pregnancy. We propose that cFLIPS/L acts as a survival factor, and performs an anti-apoptotic function in the porcine CL.

Effects of microencapsulated organic acids and essential oils on growth performance and intestinal flora in weanling pigs / Efecto de los ácidos orgánicos y aceites esenciales microencapsulados sobre el crecimiento y flora intestinal en cerdos destetos / Efeito dos ácidos orgânicos e óleos essenciais microencapsulados sob a flora intestinal e o crescimento em suínos desmamados

Background: dietary supplementation with organic acids and essential oils has positive effects on growth improvement and nutrient digestion. Microencapsulation of nutrients allow for the slow release of core materials in a specific period and/or environment. Objective: to investigate the effect of microencapsulated organic acids and essential oils (MOE) on growth performance, nutrient digestibility, blood and fecal characteristics in weanling pigs. Methods: one-hundred twenty-five weanling pigs [(Yorkshire × Landrace) x Duroc] with an average body weight (BW) of 6.76 ± 0.11 Kg were used in a 42-d experiment. Pigs were allotted to five dietary treatments according to initial body weight, using five replicates per treatment and five pigs per pen. Dietary treatments were: 1) NC (negative control): basal diet free of antibiotics; 2) PC (positive control), basal diet with tiamulin 39 mg/kg; 3) MOE0.5, basal diet with 0.5 g MOE/kg; 4) MOE1, basal diet with 1 g MOE/kg; and 5) MOE2, basal diet with 2 g MOE/kg. Results: final BW was greater in MOE2 and PC treatments compared to NC treatment (p<0.05). Increased feed efficiency (G:F) was observed for MOE treatments during 0 to 7 d compared with NC and PC (p<0.05). During 7 to 21 d, MOE0.5 and MOE1 supplementation decreased average daily feed intake (ADFI) compared with PC (p<0.05). However, there were no differences in average daily gain (ADG) and G:F among treatments (p>0.05). During 22 to 42 d, ADG was greater for PC compared with NC (p<0.05). The G:F of NC and MOE0.5 was lower than that of PC (p<0.05). Overall, ADG and G:F were greater for PC compared to NC (p<0.05). On 42 d, DM and N digestibilities in PC and MOE were greater (p<0.05) than in NC. Fecal scores of pigs fed MOE1 were lower (p<0.05) than those of pigs fed NC. Fecal pH was decreased in MOE0.5 and MOE1 when compared to NC (p<0.05) on day 7. Fecal pH was decreased with MOE compared to NC and PC (p<0.05) on d 21. Conclusion: MOE supplementation improved growth performance and nutrient digestibility while decreasing fecal scores and pH in weanling pigs.

Antecedentes: la suplementación con ácidos orgánicos y aceites esenciales mejora el crecimiento y digestibilidad de los nutrientes. Los microencapsulados permiten la lenta liberación de materiales en periodos y/o ambientes especiales. Objetivo: investigar el efecto de los ácidos orgánicos y aceites esenciales (MOE) microencapsulados sobre el crecimiento, digestibilidad de los nutrientes, y características sanguíneas y de heces en cerdos destetos. Métodos: fueron utilizados 125 cerdos destetos [(Yorkshire × Landrace) x Duroc], con un peso promedio (BW) de 6,76 ± 0,11 kg en un experimento con duración de 42 d. Los cerdos fueron asignados a 5 tratamientos dietarios de acuerdo a su peso inicial, 5 réplicas por tratamiento con 5 cerdos por corral. Los tratamientos fueron: 1) control negativo (NC), dieta básica libre de antibióticos; 2) control positivo (PC), dieta básica + tiamulina 39 mg/ kg; 3) MOE0.5, dieta básica + 0,5 g MOE/kg; 4) MOE1, dieta básica + 1 g MOE/kg; y 5) MOE2, dieta básica + 2 g MOE/kg. Resultados: el peso final fue mayor en MOE2 y PC que en NC (p<0,05). Durante los d 0 al 7, los cerdos tuvieron un incremento de la eficiencia alimenticia (G:F) con MOE en comparación con NC y PC (p<0,05). Durante los d 7 al 21, disminuyó el consumo promedio de alimento (ADFI) en los cerdos sometidos a MOE0.5 y MOE1 en comparación con PC (p<0,05). Sin embargo, no hubo diferencia significativa en la ganancia diaria de peso (ADG) y G:F comparados con PC (p<0,05). Durante los d 22 al 42, la ADG fue mayor en PC que en NC (p<0,05). En NC y MOE0.5 la G:F disminuyó en comparación con PC (p<0,05). La ADG y G:F fue mayor en PC que en NC (p<0,05). En el d 42, la digestibilidad de la materia seca y nitrógeno fue mayor (p<0,05) en PC y los suplementados con MOE que en NC. La calificación de las heces de cerdos alimentados con MOE1 fue menor (p<0,05) que la de NC. El pH fecal disminuyó (p<0,05) en MOE0.5 y MOE1 comparado con NC en el d 7. El pH fecal disminuyó en los tratamientos con MOE comparado con NC y PC en el d 21. Conclusión: la suplementación con MOE puede mejorar el crecimiento y digestibilidad de los nutrientes, y disminuir la calificación fecal y pH en cerdos destetos.

Antecedentes: a suplementação com ácidos orgânicos e óleos essenciais melhora o crescimento e a digestibilidade dos nutrientes. A microencapsulação pode permitir a liberação lenta de materiais em um período e/ou ambiente especial. Objetivo: pesquisar sobre o efeito dos ácidos orgânicos microencapsulados e óleos essenciais (MOE) no desempenho produtivo, a digestibilidade dos nutrientes, as características sanguíneas e fecais em leitões desmamados. Métodos: utilizou-se uma amostra total de 125 leitões desmamados [(York Shire × Landrace) x Duroc] com um peso corporal médio (BW) de 6,76 ± 0,11 kg testados durante 42 d. Os leitões foram distribuídos em cinco tratamentos dietéticos de acordo com seu peso corporal inicial, cinco repetições por tratamento com cinco animais por curral. Os tratamentos foram: 1) NC (controle negativo): dieta basal livre de antibióticos; 2) PC (controle positivo), dieta basal com tiamuline 39 mg/kg; 3) MOE0.5, dieta basal com 0,5 g MOE/kg; 4) MOE1, dieta basal com 1 g MOE/kg; e 5) MOE2, dieta basal com 2 g MOE/kg. Resultados: o peso final foi maior em MOE2 e PC do que NC (p<0,05). Durante 0-7 d, houve um aumento da eficiência alimentar (G: F) com MOE em comparação com NC e PC (p<0,05). Durante o período 7 a 21 d, a suplementação MOE0.5 e MOE1 diminuiu o consumo médio diário de ração (ADFI), em comparação com PC (p<0,05). No entanto, não houve diferenças em ganho de peso médio diário (ADG) e G:F entre os tratamentos (p>0,05). No período entre os 22 e 42 d, ADG foi maior no tratamento PC que NC (p<0,05). Em NC e MOE0.5 a G:F diminui-o em comparação com PC (p<0,05). Em geral, a ADG e G:F foram maiores no PC do que NC (p<0,05). No dia 42, a digestibilidade da matéria seca e nitrogênio foi maior em PC e MOE que em NC (p<0,05). A pontuação fecal de suínos alimentados com MOE1 foi menor que a NC (p<0,05). No dia 7 o pH das fezes diminuiu em MOE0.5 e MOE1 em comparação com NC (p<0,05). O pH fecal no dia 21 diminuiu com MOE em comparação com NC e PC (p<0,05). Conclusão: a suplementação com MOE pode melhorar o desempenho de crescimento e digestibilidade de nutrientes, bem como diminuir o escore fecal e pH em leitões desmamados.

Analysis of genetic diversity of salt-tolerant alfalfa germplasms.

Random amplified polymorphic DNA technology was used to analyze the genetic diversity of 25 salt-tolerant alfalfa varieties using 30 different primers. Results showed that the percentage of polymorphic loci between single-plant DNA was 81.52%, and that between mixed DNA of various varieties was 61.65%. Compared to the mixed DNA samples, single-plant DNA samples can better reveal the level of genetic variation among and between alfalfa varieties. The gene differentiation coefficients of 18 Chinese salt-tolerant alfalfa varieties and 7 American salt-tolerant alfalfa varieties were 0.271 and 0.152, respectively, showing that the exchange of genes between Chinese salt-tolerant alfalfa germplasms was more frequent than that of American germplasms. As a topical cross-pollinated plant, the genetic structure of biological populations of alfalfa was directly linked to its breeding system. According to the analysis of genetic distance (GD), 25 varieties can be divided into 9 groups, among which, the GD of Tumu No. 1 and Tumu No. 2 was the shortest (0.148), and the GD of Jieda No. 1 and Tumu was the longest (0.786). The analysis of genetic diversity of salt-tolerant alfalfa germplasms provided a theoretical basis for the creation of an alfalfa salt-tolerant core germplasm repository and for the selection and breeding of new salt-tolerant varieties.

Effect of microencapsulated blends of organic acids and essential oils supplementation on growth performance and nutrient digestibility in finishing pigs / Efecto de mezclas microencapsuladas de ácidos orgánicos y suplementos de aceites esenciales sobre el crecimiento y digestibilidad de nutrientes de cerdos en ceba / Efeito de misturas de ácidos orgânicos microencapsulados e suplementação de óleos essenciais sobre o crescimento e a digestibilidade dos nutrientes em suínos em terminação

Background: positive effects of organic acids and essential oils (MOE) on livestock are well documented. Microencapsulation allows the slow release of core materials in a specific moment or environment. Objective: to evaluate the effect of supplementing finishing pigs with microencapsulated blends of organic acids and essential oils (MOE) on growth performance, nutrient digestibility, fecal noxious gas emissions, and meat quality. Methods: 75 crossbred pigs [(Yorkshire × Landrace) × Duroc, 56.15 ± 3.77 kg] were used in this 10-week trial. Pigs were randomly distributed into 1 of 3 dietary treatments on the basis of body weight (BW) and gender. Each treatment had 5 replicate pens with 5 pigs (2 gilts, 3 barrows) per pen. Treatments were as follows: CON (a basal diet); MOE1 (CON + 0.025% MOE); MOE2 (CON + 0.050% MOE). Results: pigs fed the MOE2 diet had higher final BW at 5th and 10th week than those fed the CON diet (p<0.05). During weeks 0 to 5, MOE1 and MOE2 groups had greater average daily gain (ADG) than the CON group (p<0.05). Overall, ADG in MOE2 was greater than that in CON treatment (p<0.05). MOE2 group had higher dry matter (DM) and energy digestibility than the CON group (p<0.05). Conclusion: the present results indicate that dietary supplementation with 0.05% MOE improves growth performance and nutrient digestibility in finishing pigs.

Antecedentes: los efectos positivos de los ácidos orgánicos y aceites esenciales (MOE) en el ganado han sido documentados. La microencapsulación permite la liberación lenta del material de núcleo en un período o medio ambiente particulares. Objetivo: evaluar el efecto de suplementar cerdos de engorde con mezclas microencapsuladas de ácidos orgánicos y aceites esenciales (MOE) sobre el rendimiento productivo, la digestibilidad de nutrientes, las emisiones de gases fecales, y la calidad de la carne. Métodos: 75 cerdos cruzados [(Yorkshire × Landrace) x Duroc), 56,15 ± 3,77 kg] se utilizaron en las 10 semanas que duró el ensayo. Los cerdos se distribuyeron aleatoriamente en 1 de 3 tratamientos dietarios, de acuerdo con su peso corporal (BW) y género. Cada tratamiento tuvo 5 réplicas (corrales) con 5 cerdos por corral (2 hembras y 3 machos castrados). Los tratamientos fueron: CON (dieta basal); MOE1 (CON + 0,025% MOE); MOE2 (CON + 0,050% MOE). Resultados: los cerdos alimentados con la dieta MOE2 tuvieron mayor BW final en las semanas 5ª y 10ª que los alimentados con la dieta CON (p<0,05). Durante la semana 0 a la 5 los grupos MOE1 y MOE2 tuvieron mayor ganancia media diaria (ADG) que el grupo CON (p<0,05). En general, la ADG de MOE2 fue mayor que en el tratamiento CON (p<0,05). El grupo MOE2 tuvo mayor digestibilidad de la materia seca (DM) y de la energía que el grupo CON (p<0,05). Conclusión: los resultados indican que la suplementación de la dieta con 0,05% MOE mejora el crecimiento y la digestibilidad de nutrientes en cerdos de ceba.

Antecedentes: os efeitos positivos de ácidos orgânicos e óleos essenciais (MOE) para o gado estão bem documentados na literatura. A microencapsulação permite a liberação lenta de materiais centrais num momento ou ambiente específico. Objetivos: avaliar os efeitos de suplementação de suínos em terminação com misturas microencapsuladas de ácidos orgânicos e óleos essenciais (MOE) em pontos como desempenho produtivo, digestibilidade dos nutrientes, emissões de gases nocivos fecais e qualidade da carne. Metodologia: 75 suínos mestiços [(Yorkshire × Landrace) x Duroc), 56,15 ± 3,77 kg] foram utilizados neste teste de 10 semanas. Os animais foram selecionados aleatoriamente em 1 de 3 currais de tratamento dietético, com base no peso corporal (BW) e sexo. Cada curral teve 5 réplicas e cada curral, 5 suínos (2 fêmeas, 3 machos castrados). Os tratamentos foram os seguintes: CON (dieta basal); MOE1 (CON + 0,025% MOE); MOE2 (CON + 0,050% MOE). Resultados: os animais que receberam a dieta MOE2 apresentaram significativamente maior PV final em 5 e 10 semanas do que aqueles alimentados com a dieta CON (p<0,05). Durante 0-5 semanas, os grupos MOE1 e MOE2 tiveram maior GMD que o grupo CON (p<0,05). De um modo geral, ADG de MOE2 foi maior do que no grupo CON (p<0,05). O grupo MOE2 teve a matéria seca (DM) e a digestibilidade de energia maiores do que o grupo CON (p<0,05). Conclusão: os resultados indicam que a suplementação dietética com 0.05% de MOE melhora o desempenho do crescimento e digestibilidade de nutrientes em suínos em terminação.

Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway.

Ziyuglycoside II is an active compound of Sanguisorba officinalis L. that has anti-inflammation, antioxidation, antibiosis, and homeostasis properties. We report here on the anticancer effect of ziyuglycoside II on human gastric carcinoma BGC-823 cells. We investigated the effects of ziyuglycoside II on cell growth, cell cycle, and cell apoptosis of this cell line. Our results revealed that ziyuglycoside II could inhibit the proliferation of BGC-823 cells by inducing apoptosis but not cell cycle arrest, which was associated with regulation of Bax/Bcl-2 expression, and activation of the caspase-3 pathway. Our study is the first to report the antitumor potential of ziyuglycoside II in BGC-823 gastric cancer cells. Ziyuglycoside II may become a potential therapeutic agent against gastric cancer in the future.

Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway

Ziyuglycoside II is an active compound of Sanguisorba officinalis L. that has anti-inflammation, antioxidation, antibiosis, and homeostasis properties. We report here on the anticancer effect of ziyuglycoside II on human gastric carcinoma BGC-823 cells. We investigated the effects of ziyuglycoside II on cell growth, cell cycle, and cell apoptosis of this cell line. Our results revealed that ziyuglycoside II could inhibit the proliferation of BGC-823 cells by inducing apoptosis but not cell cycle arrest, which was associated with regulation of Bax/Bcl-2 expression, and activation of the caspase-3 pathway. Our study is the first to report the antitumor potential of ziyuglycoside II in BGC-823 gastric cancer cells. Ziyuglycoside II may become a potential therapeutic agent against gastric cancer in the future.